课题基金 / 基金详情

E COLI VIRULENCE TRAITS IN INTRAABDOMINAL INFECTION

E COLI VIRULENCE TRAITS IN INTRAABDOMINAL INFECTION
腹内感染中的大肠杆菌毒力特征
批准号:
3455409
负责人:
TIMOTHY L PRUETT
金额:
$10.85万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1990
资助国家:
美国
项目状态:
已结题
起止时间:
1990-02-01 至 1995-01-31

项目摘要

项目成果

TIMOTHY L PRUETT的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In spite of advances in surgical techniques, critical care facilities, diagnostic capacities, and improvements in antimicrobial therapy, the mortality from intraabdominal infection remains high. A recent experience from five university intensive care units reported an overall mortality of 28% from intraabdominal infection. The magnitude of the clinical problem necessitates continued basic research. The peritoneal cavity possesses a remarkable capacity to combat infection. Surgical predecessors have laid the groundwork of defining the mechanics whereby this region of the body handles infection. These are typically described as: a) rapid dispersal of particulate matter (including bacteria) via diaphragmatic lymphatics lacunae; b) rapid upregulation of phagocytic capacity within the peritoneum within 2-6 hours after bacterial introduction; and c) mechanical sequestration of bacteria by fibrin trapping and obliteration of dead space by paralytic ileus. An important consideration missing from the majority of these studies is the alteration in outcome predicated upon rapid adaptive changes of the infecting organisms. All bacteria do not possess the same ability to produce infection and many can undergo significant phenotypic changes in different environments. The specific aim of this proposal is to understand how the most frequently recovered bacteria from intraabdominal infection, Escherichia coli, evolves during peritoneal infection. These organisms are not inert, but actively change their metabolic pathways and physical properties to survive in a hostile environment. The goals of the project are to determine: 1) the intraperitoneal kinetics of varying wild types and laboratory strains of E. coli, and correlate known virulence traits (O and K antigens, alpha-hemolysin production, ability to adhere to mammalian cells, and the expression of outer membrane proteins) to survivability within the peritoneum. 2) the effect of adjuvants of intraperitoneal infection (hemoglobin, bile salts, stool, mucin) upon the infectivity of E. coli and correlation with virulence. 3) the traits of E. coli which promote mixed infections: in particular with the most common anaerobe, Bacteroides fragilis. An improved prognosis for patients with intraabdominal infection will occur when physicians understand not only the manner in which the host defenses interact with infecting organisms, but also the adaptive mechanisms employed by the bacteria to survive within the host peritoneum. It is the purpose of this proposal to begin the process of delineating these mechanisms.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PHARMACOKINETICS OF ABBOTT CYCLOSPORINE FOLLOWING LIVER TRANSPLANT
  • 批准号:
    6579037
  • 项目类别:
  • 资助金额:
    $4.85万
  • 财政年份:
    2002
  • 负责人:
    TIMOTHY L PRUETT
  • 依托单位:
PHARMACOKINETIC COMPARISON OF NEORAL TO ABBOTT CYCLOSPORINE
  • 批准号:
    6578935
  • 项目类别:
  • 资助金额:
    $4.85万
  • 财政年份:
    2002
  • 负责人:
    TIMOTHY L PRUETT
  • 依托单位:
PHARMACOKINETICS OF ABBOTT CYCLOSPORINE FOLLOWING LIVER TRANSPLANT
  • 批准号:
    6477564
  • 项目类别:
  • 资助金额:
    $4.85万
  • 财政年份:
    2001
  • 负责人:
    TIMOTHY L PRUETT
  • 依托单位:
PHARMACOKINETIC COMPARISON OF NEORAL TO ABBOTT CYCLOSPORINE
  • 批准号:
    6477462
  • 项目类别:
  • 资助金额:
    $4.85万
  • 财政年份:
    2001
  • 负责人:
    TIMOTHY L PRUETT
  • 依托单位:
国内基金
海外基金
asr基因调控酸诱导的Escherichia coli O157:H7形成VBNC状态的机制研究
  • 批准号:
    32302245
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2023
  • 负责人:
    潘寒姁
  • 依托单位:
小肠中Escherichia coli分泌细菌毒素诱导肠屏障损伤及细菌易位在炎症性肠病中的机制研究
  • 批准号:
    82371775
  • 项目类别:
    面上项目
  • 资助金额:
    46万元
  • 批准年份:
    2023
  • 负责人:
    朱慧媛
  • 依托单位:
基于Escherichia coli O157:H7亚致死态细胞探究超高压与原儿茶酸协同杀菌机制
  • 批准号:
    31871817
  • 项目类别:
    面上项目
  • 资助金额:
    60.0万元
  • 批准年份:
    2018
  • 负责人:
    孙爱东
  • 依托单位:
肠肝轴:从临床患者分离的肠道致病菌株Escherichia coli NF73-1对非酒精性脂肪性肝病的作用及机制研究
  • 批准号:
    81873549
  • 项目类别:
    面上项目
  • 资助金额:
    57.0万元
  • 批准年份:
    2018
  • 负责人:
    刘玉兰
  • 依托单位: